Sensitive DNA Methylation Detection Using Droplet Digital PCR
Whitepaper
Published: July 10, 2024
|
Last Updated: August 13, 2024
Credit: iStock
DNA methylation plays a critical role in developmental and physiological processes, where aberrant methylation can lead to a variety of disease states including cancer.
Cell-free DNA (cfDNA) samples are used to detect methylation changes, but sensitive, robust and cost-effective analysis methods remain an unmet need.
This whitepaper demonstrates how common methylation detection methods can be combined with Droplet Digital PCR (ddPCR) to enhance the cfDNA analysis for clinical and research applications.
Download this whitepaper to learn more about:
- Critical parameters for ddPCR assay design
- The advantages of methylation detection using MSRE ddPCR
- Considerations for choosing a cytosine deamination method
DNA Methylation Detection
Using Droplet Digital" PCR
Hamutal Bonen, PhD; Jeremiah McDole, PhD; Eddy van Collenburg
Bio-Rad Laboratories, Inc., Digital Biology Center, 5731 W Las Positas Blvd, Pleasanton, CA 94588
Abstract
The year 2023 marks 12 years since the advent of Droplet Digital PCR (ddPCR™). In that time, ddPCR
technology has revolutionized the absolute quantification of nucleic acids. With a host of technical advances
and enhanced automation in recent years, Droplet Digital PCR is moving from a specialized research
technique to a robust tool in clinical and translation research applications. This white paper reviews the
use of Droplet Digital PCR for detection of DNA methylation. We review ddPCR technology, compare
different workflow strategies, and explain critical parameters for optimal assay design to get unprecedented
sensitivity, linearity, and robustness when detecting DNA methylation by Droplet Digital PCR.
Introduction
DNA methylation plays a critical role in many normal developmental
and sustaining physiological processes. However, aberrant
methylation can lead to a variety of disease states, including
several types of cancer. For instance, global hypomethylation can
contribute to the activation of oncogenes while hypermethylation
within tumor suppressor genes can result in silencing. Mounting
evidence demonstrates the utility of analyzing methylation status
as an indicator of early-stage cancer development and as a
method for monitoring tumor response to therapy. Detecting
methylation changes in cell-free DNA (cfDNA) is especially
attractive given the noninvasive nature of blood draws.
Unfortunately, sensitive, robust, and cost-effective methods to
perform methylation analysis on cfDNA samples remain an unmet
need. Here we demonstrate how common methylation detection
methods combine with Droplet Digital PCR to enhance analysis of these precious samples.
DNA Digestion Using Methylation-Sensitive Restriction
Enzymes (MSRE)
By far, the fastest and easiest method of DNA methylation
quantification incorporates MSRE digestion. Further, this method does
not have the drawbacks of bisulfite conversion, such as extensive
DNA degradation and high starting material input requirements.
As shown in the schematic below, methylation-sensitive restriction
enzymes do not cleave restriction sites in the presence of a
methylated cytosine, leading to PCR amplification (Figure 1), while cleavage of an unmethylated site inhibits amplification.
Unmethylated
Restriction Site
Cleavage
No
Amplification
E
Amplification
Methylated
Restriction Site
M
No Cleavage
Fig. 1. Schematic overview of methylation-sensitive restriction enzyme
digestion. M, methyl; MSRE, methylation-sensitive restriction enzyme.
There are a variety of commercially available MSREs available
(Table 1). Specific primers can be designed to amplify a specific
sequence of interest that contains an MSRE. See the Primer
Design section for recommendations on how to design primers.
MSRE
PCR
Restriction Site
CGICG
GC+GC
CĮCGC
GGC1G
CĮCGG
GGC1C
GCGĮC
C1GCG
To detect the methylation status at a specific locus, the sample
is digested by a methylation-sensitive restriction enzyme and
analyzed with Droplet Digital PCR (Figure 2). When using probe-
based detection methods, multiplexing several methylation sites
or targets is possible. For best results, a duplex reaction with a
reference target (no restriction sites) is advised (e.g., RPP30).
The reference assay is used to normalize and correct for small
input differences caused by pipetting or samples with unstable
copy number.
Methylation percentages are calculated with high precision via
Droplet Digital PCR by measuring DNA concentrations in samples
with (MSRE+) and without (MSRE-) enzyme. The percentage of
methylation, or methylation fraction, is calculated using the precise
ddPCR concentrations measured for samples either digested
(MSRE+) or undigested (MSRE-), as follows:
MSRE+ ratio = target concentration/reference concentration
MSRE-ratio = target concentration/reference concentration
% methylation = MSRE+ ratio/MSRE- ratio
Note that copy number results are available from the undigested
(MSRE-) samples and can be used to detect differences in
samples (assuming the use of a stable reference gene).
DNA Methylation Detection Using Droplet Digital PCR
Table 1. Overview of MSREs and restriction site sequences.
Restriction Enzyme (all 4-base cutters)
Accll (BstUl, Bsh12361)
Acil (Ssil)
Hpall (Hapll)
Hhal (Cfol)
Temperature, C
95
95
55
98
12
Droplet reading can be performed on a QX200T or QX600TM
Droplet Reader. All the data shown in this white paper were
generated using a QX200 Droplet Reader.
Cycling Step
Enzyme activation
Denaturation
Annealing/extension
Enzyme deactivation
Hold
Time
10 min
30 sec
1 min
10 min
<48 hr
Samples are prepared as follows (incubations can be done in a
thermal cycler such as the T100 Thermal Cycler):
. MSRE+ samples - 50-100 ng of DNA is incubated for 1 hr at
60°C with 2-10 U of BstUl and 0.5 ul 10x CutSmart Buffer (New
England Biolabs, Inc., discontinued; rCutSmart Buffer [#B6004S]
is a suitable alternative) in a total volume of 5.0 pl.
. MSRE-samples - 50-100 ng of DNA is incubated for 1 hr at
60°C with 0.5 ul 10x CutSmart Buffer in a total volume of 5.0 ul.
In a 22 ul experiment, 1-100 ng of incubated DNA samples can be
analyzed using 11 ul ddPCR Supermix for Probes (No dUTP)
(Bio-Rad Laboratories, Inc., catalog #1863024) and primers and
probes in a final concentration of 900 and 250 nM, respectively.
PCR mixtures are partitioned into ~20,000 droplets using the
Automated Droplet Generator (Bio-Rad, #1864101). Subsequent
PCR is performed in a thermal cycler using the the protocol
outlined in Table 2.
Table 2. Thermal cycling protocol. Ramp rate set to 2C/sec for all steps.
Number of Cycles
1
40
1
Concen
Methylated MSRE- Methylated MSRE+
Unmethylated
MSRE-
MSRE+ Ratio
MSRE-Ratio
Methylation, %
2.50
Unmethylated
MSRE+
Fig. 3. PTGER4 promotor (FAM) and RPP30 (HEX). One-dimensional plots show
the positive and negative droplet clusters from two targets run in duplex, PTGER4
(FAM, AssaylD dHsaEXD82842910) and RPP30 (HEX, AssaylD dHsaCP2500350).
Two-dimensional plot shows the four clusters from the same reaction. Hpall is used
for digestion. Concentrations (copies/ul) are shown in the bottom graph and used
for calculating the percentage of methylation from each sample (see calculations).
MSRE, methylation-sensitive restriction enzyme.
PTGER4 Promoter (FAM) and RPP30 (HEX)
The percentage of PTGER4 promoter methylation was calculated
as shown in Table 3.
Table 3. PTGER4 promoter methylation calculations.
Methylated
175/185 = 0.946
179/183 = 0.978
0.946/0.978 = 97%
2023 Bio-Rad Laboratories, Inc.
Unmethylated
2.39/249 = 0.0096
272/252 = 1.079
0.0096/1.079 = 0.9%
MSRE+ Ratio
MSRE-Ratio
Methylation, %
Methylated MSRE- Methylated MSRE+
Fig. 4. SEPT9 CGI3 promotor (FAM) and RPP30 (HEX). One-dimensional plots
show the positive and negative droplet clusters from two targets run in duplex,
SEPT9 CGI3 (FAM, AssaylD dHsaEXD18126781) and RPP30 (HEX, AssayID
dHsaCP2500350). Two-dimensional plot shows the four clusters from the same
reaction. BstUl is used for digestion. Concentrations (copies/ul) are shown in the
bottom graph and used for calculating the percentage of methylation from each
sample (see calculations). MSRE, methylation-sensitive restriction enzyme.
The percentage of SEPT9 promoter methylation was calculated as
shown in Table 4.
Table 4. SEPT9 promoter methylation calculations.
Methylated
335/208 = 1.611
350/217 = 1.613
1.611/1.613 = 100%
Unmethylated
MSRE-
Unmethylated
MSRE+
Unmethylated
2.33/266 = 0.0088
271/272 = 0.996
0.0088/0.996 = 0.9%
Bulletin 3585
[Buner)
Fig. 5. Probe Mix Triplex WIF1 (FAM), NPY (FAM), and RPP30 (0.4x FAM, 0.25x
HEX). One-dimensional plots show the positive and negative droplet clusters from
three targets run in triplex. WIF1 (FAM, AssaylD dHsaEXD31159278), NPY (FAM,
AssaylD dHsaEXD18238370), and RPP30 (0.4x FAM, AssaylD dHsaCP2500313,
0.25x HEX, AssayID dHsaCP2500350). Two-dimensional plot shows up to eight
clusters from the same reaction. A mixture of Acil and Hhal was used for digestion.
Two replicate reactions of an unmethylated control sample were used to compare
the digestion in sample (buffer: digestion overnight) with the digestion in master mix
(sample: 45 min at room temperature). Concentrations (copies/ul) are shown in the
bottom graph and used for calculating the percentage of methylation from each
sample (see calculations). MSRE, methylation-sensitive restriction enzyme.
WIF1
MSRE+ Ratio
MSRE-Ratio
Methylation, %
NPY
MSRE+ Ratio
MSRE-Ratio
Methylation, %
WIF1 and NPY methylation was calculated as shown in Table 5.
Table 5. WIF1 and NPY methylation calculations.
Overnight Digestion
0.345/56 = 0.0062
53.7/57.9 = 0.927
0.0062/0.927 = 0.7%
5.48/56 = 0.0979
58.3/57.9 = 1.007
0.0979/1.007 = 9.7%
ddPCR Assay Design
Since analysis is based on restriction enzyme cleavage, the
amplicon sequence must include cleavage sites. This approach
provides high specificity, however only specific restriction sites can
be analyzed, which can be a limitation. To reliably measure DNA
methylation, we recommend including at least two but not more
than four restriction sites in the amplicon. If a single MSRE cannot
cut at least two sites in an amplicon, combining multiple MSREs
that cut within the amplicon is a good alternative. For an extended
overview on how to design specific ddPCR assays, please refer to
the Assay Design for Droplet Digital PCR section in bulletin 6407.
Consider the following when designing primers:
. Check for restriction sites within the area of your target sequence
. Look for restriction enzymes that have 2 or more restriction sites
close together
. Design primers outside these restriction sites to produce an
amplicon with 2 or more restriction sites
A restriction site can be included in the primers but only in
the last 4 nucleotides of the 3' end of each of the primers.
Restriction sites outside the primers are preferred
Short amplicons (<100 nucleotides) enable fragmented sample
analysis (e.g., formalin-fixed paraffin-embedded [FFPE] or
circulating tumor DNA [ctDNA])
. Combining different restriction enzymes is possible and used to
perform double digestions in the same reaction
Example Assay Design
Figure 6 shows an example assay design for the transcription
factor one cut homeobox 2 (ONECUT2).
Amplicon: 64 bp, location hg19|chr18:55103715-55103778:+
Sequence: AAATGCTCAGCCCCAACTTCGACGCGCACCACACT
GCCATGCTGACCCGCGGTGAGCAACACC
Fig. 6. Example assay design for the transcription factor ONECUT2 (BstUl
restriction sites). Bio-Rad PrimePCR AssaylD: dHsaEXD31605634. BstUl sites are
bolded, primer sites are underlined, and the probe site is highlighted yellow. Chr,
chromosome; hg, human genome.
ddPCR Master Mix Digestion
0.0559/53.7 = 0.00104
53.7/57.9 = 0.927
0.00104/0.927 = 0.1%
5.16/53.7 = 0.0961
58.3/57.9 = 1.007
0.0961/1.007 = 9.5%
Cytosine Deamination
While MSRE digestion protocols are rapid and reliable, sodium
bisulfite conversion is the current gold standard of methylation
analysis. In this method, DNA is denatured and treated with sodium
bisulfite. This process deaminates unmethylated cytosine in DNA to
uracil and leaves methylated cytosines unchanged. Amplifying the
treated DNA with PCR converts uracils further to thymines while
the methylated cytosines remain cytosines. An example of cytosine
deamination is shown in Figure 7.
Although bisulfite treatment is relatively fast and straightforward,
it requires elevated temperatures and high pH that can
damage DNA, resulting in fragmentation and depyrimidination.
Unmethylated cytosines are especially sensitive to degradation
with this method, resulting in challenges amplifying GC-rich areas.
A less damaging method for cytosine deamination was recently
developed by New England Biolabs, Inc. (NEB). In this method,
APOBEC enzyme is used to convert cytosine to uracil, resulting in
far less DNA degradation. However, APOBEC can also deaminate
5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC). To
protect the methylated cytosine from deamination, NEB uses TET2
enzyme and Oxidation Enhancer (#E7129) to modify 5mC and
5hmC to forms that are not substrates for APOBEC.
When deciding which method to utilize, the required starting
material should be considered. Sodium bisulfite protocols
typically require between 0.1 and 2 g of DNA (depending on the
manufacturer) while the enzymatic approach can be performed
with much less.
Since both methods rely on the conversion of unmethylated DNA
to thymine, primers and probe designs are the same for both.
Primer Design
There are two main design strategies available to specifically
amplify converted (unmethylated) and unconverted (methylated)
sequences with Droplet Digital PCR: methylation-specific primers
and methylation-independent primers (Figure 8).
Primer design considerations for methylation-specific primers:
. Include as many CpG sites as possible, especially at the 3' end
of the primer
. Consider the same CpG sites in the primer sequence for
methylated DNA and unmethylated DNA
Maximize specificity by using a detection probe including CpG sites
Primer design considerations for methylation-independent primers:
. No CpG sites within the primer sequence
Use an adequate number of C (no CpG)
Spanning a maximum number of CpG sites in the amplicon
Maximize specificity by using a detection probe including CpG sites
Brought to you by
Access this Whitepaper for FREE Now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
Experiencing issues viewing the form? Click here to access an alternate version